The Ulocuplumab Biosimilar Anti-CXCR4 Antibody is a cutting-edge product designed for research involving the CXCR4 protein, a key player in cell migration and cancer metastasis. This biosimilar antibody, developed through advanced technology, exhibits high specificity and affinity for the CXCR4 molecule, allowing for accurate detection and analysis in various experimental settings.CXCR4, a chemokine receptor, is known to play a critical role in tumor growth, angiogenesis, and metastasis in various types of cancer. By targeting CXCR4 with this antibody, researchers can explore its mechanisms of action in cancer progression and potentially develop novel therapies to combat metastatic disease.
The Ulocuplumab Biosimilar Anti-CXCR4 Antibody offers a reliable tool for investigating the role of CXCR4 in cancer biology and identifying potential therapeutic targets for anti-cancer treatments. With its proven effectiveness in research studies, this antibody is a valuable asset for scientists and researchers working in the fields of oncology and cancer biology.
Product Name:
Ulocuplumab (Anti-CXCR4) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0089
Target:
CXCR4
Host Species:
Homo sapiens
Reactivity:
Human
Recommended Dilution:
Flow Cyt 1:100
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
BMS-936564, MDX-1338
Description:
Anti-CXCR4(ulocuplumab biosimilar) mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
Flow Cyt
Antibody Isotype:
IgG4
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.